Physician profile
James E Camel
NPI 1568576635
$19,437.87
in general payments reported to CMS, 2019-2025
10 companies · $2,398 in 2025
The $2,398 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,268 · 2020: $97.99 · 2021: $51.85 · 2022: $1,076 · 2023: $4,392 · 2024: $3,154 · 2025: $2,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $3,029 · Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $3,028.69 |
| Food and Beverage | $1,415.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,559.09 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Acell, INC. | $4,587.46 | 2019 | |
| Davol INC. | $3,713.49 | 2020-2025 | Phasix Mesh |
| Covidien Lp | $165.87 | 2019 | |
| Integra Lifesciences Corporation | $130.86 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Kci USA, INC. | $122.12 | 2019 | |
| Teleflex LLC | $66.67 | 2019 | |
| Stryker Corporation | $54.26 | 2023 | Core, Na, Sonopet Iq |
| Shionogi INC | $20.33 | 2022 | |
| Tela Bio, INC. | $17.72 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Camel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.